Aminocaproic Acid

Aminocaproic acid is a specific active drug ingredient rather than a formal therapeutic class; clinically, it is categorized within the antifibrinolytic class of hemostatic agents It functions as a synthetic lysine analogue that competitively binds to the lysine-binding sites on plasminogen, thereby inhibiting plasminogen activation and preventing fibrin degradation to stabilize formed blood clots

Aminocaproic acid is a specific active drug ingredient rather than a formal therapeutic class; clinically, it is categorized within the antifibrinolytic class of hemostatic agents

Aminocaproic acid is a specific active drug ingredient rather than a formal therapeutic class; clinically, it is categorized within the antifibrinolytic class of hemostatic agents

It functions as a synthetic lysine analogue that competitively binds to the lysine-binding sites on plasminogen, thereby inhibiting plasminogen activation and preventing fibrin degradation to stabilize formed blood clots

It functions as a synthetic lysine analogue that competitively binds to the lysine-binding sites on plasminogen, thereby inhibiting plasminogen activation and preventing fibrin degradation to stabilize formed blood clots Aminocaproic acid is primarily utilized to manage and prevent acute or excessive hemorrhage in clinical settings where hyperfibrinolysis contributes to bleeding, such as during cardiac surgery, dental procedures in patients with coagulopathies, and severe trauma